Neutrophil-derived ROS secretion in B16F10 melanoma and Hepa1-6 hepatoma suppress IL-17+ γδ T cells which have pro-tumoral features, but not CD8+ T cells, in tumor niches (116). Here, IL17A is linked to neoplasm.